Annual report [Section 13 and 15(d), not S-K Item 405]

Financial Instruments - Additional Information (Details)

v3.26.1
Financial Instruments - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration payable $ 2,319 $ 3,127
Accounts Payable and Accrued Liabilities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration payable $ 1,100  
Maximum [Member] | Level 3 [Member] | 2026 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 89.00%  
Maximum [Member] | Level 3 [Member] | 2027 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 20.00%  
Minimum [Member] | Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Company's incremental borrowing rate 13.90%  
Minimum [Member] | Level 3 [Member] | 2026 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 36.00%  
Minimum [Member] | Level 3 [Member] | 2027 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 0.00%